| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |